These samples are derived from individuals affected with neuromuscular or rare diseases but also from healthy subjects in order to provide a batch of ‘control’ material. This biological material is intended for in vitro studies, which supplement the knowledge obtained from animal models before a clinical investigation in vivo.
 
The service is available on request, to all research teams, French and foreign. Each application is examined by the RTB in order to ensure that the project conforms with the principles applied to the collection and use of human tissue. It is validated by the medical and scientific director of the Myology Institute Association.